Status: current, Defined. Date: 31-Jul 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4587131000168114 | Sitagliptin (BPA) (sitagliptin 25 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4587141000168117 | Sitagliptin (BPA) 25 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sitagliptin (BPA) 25 mg tablet | Is a | Sitagliptin (BPA) | true | Inferred relationship | Some | ||
| Sitagliptin (BPA) 25 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Sitagliptin (BPA) 25 mg tablet | Is a | sitagliptin 25 mg tablet | true | Inferred relationship | Some | ||
| Sitagliptin (BPA) 25 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Sitagliptin (BPA) 25 mg tablet | has intended active ingredient | sitagliptin | true | Inferred relationship | Some | 136430005 | |
| Sitagliptin (BPA) 25 mg tablet | has Australian BoSS | sitagliptin | true | Inferred relationship | Some | 136430005 | |
| Sitagliptin (BPA) 25 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1077579326 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sitagliptin (BPA) 25 mg tablet, 30, blister pack | has TPUU | True | Sitagliptin (BPA) 25 mg tablet | Inferred relationship | Some | 1137624606 |
| Sitagliptin (BPA) 25 mg tablet, 30 | has TPUU | True | Sitagliptin (BPA) 25 mg tablet | Inferred relationship | Some | 1635921822 |
Reference Sets
Trade product unit of use reference set
FHIR